Literature DB >> 19739070

Mismatch repair system decreases cell survival by stabilizing the tetraploid G1 arrest in response to SN-38.

Mandar Ramesh Bhonde1, Marie-Luise Hanski, Jenny Stehr, Britta Jebautzke, Roser Peiró-Jordán, Henry Fechner, Kazunari Kazushige Yokoyama, Weei-Chin Lin, Martin Zeitz, Christoph Hanski.   

Abstract

The role of the mismatch repair (MMR) system in correcting base-base mismatches is well established; its involvement in the response to DNA double strand breaks, however, is less clear. We investigated the influence of the essential component of MMR, the hMLH1 protein, on the cellular response to DNA-double strand breaks induced by treatment with SN-38, the active metabolite of topoisomerase I inhibitor irinotecan, in a strictly isogenic cell system (p53(wt), hMLH1(+)/p53(wt), hMLH1(-)). By using hMLH1 expressing clones or cells transduced with the hMLH1-expressing adenovirus as well as siRNA technology, we show that in response to SN-38-induced DNA damage the MMR proficient (MMR(+)) cells make: (i) a stronger G2/M arrest, (ii) a subsequent longer tetraploid G1 arrest, (iii) a stronger activation of Chk1 and Chk2 kinases than the MMR deficient (MMR(-)) counterparts. Both Cdk2 and Cdk4 kinases contribute to the basal tetraploid G1 arrest in MMR(+) and MMR(-) cells. Although the Chk1 kinase is involved in the G2/M arrest, neither Chk1 nor Chk2 are involved in the enhancement of the tetraploid G1 arrest. The long-lasting tetraploid G1 arrest of MMR(+) cells is associated with their lower clonogenic survival after SN-38 treatment, the abrogation of the tetraploid G1 arrest resulted in their better clonogenic survival. These data show that the stabilization of the tetraploid G1 arrest in response to double strand breaks is a novel function of the MMR system that contributes to the lesser survival of MMR(+) cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19739070      PMCID: PMC4205106          DOI: 10.1002/ijc.24893

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  28 in total

Review 1.  G2 and spindle assembly checkpoint adaptation, and tetraploidy arrest: implications for intrinsic and chemically induced genomic instability.

Authors:  Paul R Andreassen; Olivier D Lohez; Robert L Margolis
Journal:  Mutat Res       Date:  2003-11-27       Impact factor: 2.433

Review 2.  G1 tetraploidy checkpoint and the suppression of tumorigenesis.

Authors:  Robert L Margolis; Olivier D Lohez; Paul R Andreassen
Journal:  J Cell Biochem       Date:  2003-03-01       Impact factor: 4.429

3.  Is mismatch repair really required for ionizing radiation-induced DNA damage signaling?

Authors:  Petr Cejka; Lovorka Stojic; Giancarlo Marra; Josef Jiricny
Journal:  Nat Genet       Date:  2004-05       Impact factor: 38.330

4.  Loss of DNA mismatch repair imparts defective cdc2 signaling and G(2) arrest responses without altering survival after ionizing radiation.

Authors:  T Yan; J E Schupp; H S Hwang; M W Wagner; S E Berry; S Strickfaden; M L Veigl; W D Sedwick; D A Boothman; T J Kinsella
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

5.  Cellular effects of CPT-11 on colon carcinoma cells: dependence on p53 and hMLH1 status.

Authors:  Roberta Magrini; Mandar R Bhonde; Marie-Luise Hanski; Michael Notter; Hans Scherübl; C Richard Boland; Martin Zeitz; Christoph Hanski
Journal:  Int J Cancer       Date:  2002-09-01       Impact factor: 7.396

6.  Structural basis for UCN-01 (7-hydroxystaurosporine) specificity and PDK1 (3-phosphoinositide-dependent protein kinase-1) inhibition.

Authors:  David Komander; Gursant S Kular; Jennifer Bain; Matthew Elliott; Dario R Alessi; Daan M F Van Aalten
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

7.  p53 disruption profoundly alters the response of human glioblastoma cells to DNA topoisomerase I inhibition.

Authors:  Yinglin Wang; Shaojun Zhu; Timothy F Cloughesy; Linda M Liau; Paul S Mischel
Journal:  Oncogene       Date:  2004-02-12       Impact factor: 9.867

8.  An Msh2 point mutation uncouples DNA mismatch repair and apoptosis.

Authors:  Diana P Lin; Yuxun Wang; Stefan J Scherer; Alan B Clark; Kan Yang; Elena Avdievich; Bo Jin; Uwe Werling; Tchaiko Parris; Naoto Kurihara; Asad Umar; Raju Kucherlapati; Martin Lipkin; Thomas A Kunkel; Winfried Edelmann
Journal:  Cancer Res       Date:  2004-01-15       Impact factor: 12.701

9.  The Chk2 tumor suppressor is not required for p53 responses in human cancer cells.

Authors:  Prasad V Jallepalli; Christoph Lengauer; Bert Vogelstein; Fred Bunz
Journal:  J Biol Chem       Date:  2003-03-24       Impact factor: 5.157

10.  Karyopherin-alpha2 protein interacts with Chk2 and contributes to its nuclear import.

Authors:  Laura Zannini; Daniele Lecis; Sofia Lisanti; Roberta Benetti; Giacomo Buscemi; Claudio Schneider; Domenico Delia
Journal:  J Biol Chem       Date:  2003-08-09       Impact factor: 5.157

View more
  2 in total

1.  Association between mismatch repair gene and irinotecan-based chemotherapy in metastatic colon cancer.

Authors:  Junli Ma; Yan Zhang; Hong Shen; Linda Kapesa; Wenqiang Liu; Mengsi Zeng; Shan Zeng
Journal:  Tumour Biol       Date:  2015-07-05

Review 2.  Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer.

Authors:  Cong-Min Zhang; Jin-Feng Lv; Liang Gong; Lin-Yu Yu; Xiao-Ping Chen; Hong-Hao Zhou; Lan Fan
Journal:  Int J Environ Res Public Health       Date:  2016-09-08       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.